Home > Article

Premarket roundup: Acadia, Tempur-Pedic

By Associated Press

June 17, 2008

Recommended (0)

Among the premarket stories for Tuesday, June 17, from AP Financial News:

NEW YORK (AP) _ Analysts turned their attention to Acadia Pharmaceuticals Inc.'s future and its drug candidate pimavanserin Tuesday, a day after the company reported the failure of another schizophrenia drug.

NEW YORK (AP) _ Premium mattress sellers such as Tempur-Pedic International Inc. are seeing weaker business from the broader economic slowdown and show little sign of improvement in the near term, an Oppenheimer analyst said Tuesday.

NEW YORK (AP) _ Analysts disagreed Tuesday on whether shares of Adobe Systems Inc. remain attractive, due in part to concern over the launch of new software and despite a jump in fiscal second-quarter earnings.

Comment (0)

Recommended (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment icon found on every comment.

Be the first one to comment on this article.

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Compare Brokers

DocumentId: 666197, ~/articles/articlehandler.aspx, 10/13/2008 7:06:57 PM,

Sign up for FREE Motley Fool site access!

Already registered? Login Here

It’s FREE! Enter your email address, and we’ll rush you to the article you're looking for right now.

Privacy / Legal Information

We will use your email address only to keep you informed about updates to our web site and about other products and services that we think might interest you. The Motley Fool respects your privacy. Please read our Privacy Statement